medRxivGenetic & Genomic MedicinePreprint
Genetic Determinants of Pulmonary Artery Size in over 50,000 Subjects with and without COPD
Vasile ForisiD, Kangjin KimiD, Courtney TerniD, Yunzhe QianiD, Junsun YuiD, George R. WashkoiD, R. Chad WadeiD, James Michael WellsiD, Honghuang LiniD, George T. O’ConnoriD, Albert V. SmithiD, Stacey GabrieliD, Namrata GuptaiD, Edwin K. SilvermaniD, Adel R. BoueiziD, Michael H. ChoiD
Abstract
RationalePulmonary artery (PA) enlargement is a non-invasive imaging biomarker associated with pulmonary hypertension and mortality in COPD; however, its genetic determinants remain incompletely understood. ObjectivesTo characterize the genetic architecture of PA size across COPD-enriched and population-based cohorts. MethodsWe performed genome-wide association analyses of PA diameter using whole-genome sequencing in COPDGene (n=9,418) and ECLIPSE (n=1,859), and imputed-genotype data from the UK Biobank (n=37,073). We replicated lead variants in the Framingham Heart Study (FHS; n=3,289), incorporated all four studies into a joint meta-analysis, and identified independent signals through conditional analyses. Candidate effector genes were prioritized using coding variant annotation, colocalization, and integrative regulatory evidence. Measurements and Main ResultsWe identified 44 independent genome-wide significant PA diameter signals within 39 loci, including 8 variants replicated in FHS, novel associations near FRMD4B, SLC20A2, BORCS7-ASMT, and KCNRG, and 5 signals in conditional analysis including multiple signals at ANO1. Genetic effects were concordant across imaging modalities and cohorts of differing COPD burden. Effector-gene prioritization nominated ABCC8, PDGFD, HMCN1, CCNE1, and TBX20, implicating pathways in vascular remodeling, developmental regulation, smooth muscle and endothelial function, ion-channel signaling, and extracellular matrix organization. Colocalization with pulse pressure GWAS demonstrated substantial shared causal variation between pulmonary and systemic vascular biology. ConclusionsIn this largest genetic study of pulmonary vascular imaging to date, PA diameter exhibits a polygenic architecture consistent across imaging modalities and cohorts of differing COPD burden. The prioritized effector genes bridge rare-variant pulmonary hypertension biology with common-variant systemic vascular biology.
- organism: human
- assay: GWAS summary statistics
- research focus: GWAS / association mapping
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genetic determinants of risk and survival in pulmonary arterial hypertension
Christopher J. Rhodes, Ken Batai, … Quinten Waisfisz·The Lancet Respiratory MedicinePeer-reviewed·Dec 5, 2018
- Rare variant analysis of 4,241 pulmonary arterial hypertension cases from an international consortium implicate FBLN2, PDGFD and rare de novo variants in PAH
Na Zhu, Emilia M. Swietlik, … National Cohort Study of Idiopathic and Heritable PAH·Genome MedicinePeer-reviewed·May 10, 2021
- Defining the Clinical Validity of Genes Reported to Cause Pulmonary Arterial Hypertension
Carrie L. Welch, Micheala A. Aldred, … Dmitry A. Zateyshchikov·Genetics in MedicinePeer-reviewed·Jul 5, 2023
- New genetic signals for lung function highlight pathways and pleiotropy, and chronic obstructive pulmonary disease associations across multiple ancestries
Nick R. G. Shrine, Anna L. Guyatt, … Andrew P. Morris·Nature GeneticsPeer-reviewed·Feb 25, 2019
- Role of Forkhead box F1 in the Pathobiology of Pulmonary Arterial Hypertension
Jose G. Gomez‐Arroyo, Arjan C. Houweling, … William C. Nichols·bioRxiv·Sep 18, 2024
- Novel risk genes and mechanisms implicated by exome sequencing of 2,572 individuals with pulmonary arterial hypertension
Na Zhu, Michael W. Pauciulo, … William C. Nichols·Genome MedicinePeer-reviewed·Nov 14, 2019